News
Filter
-
Driving translational research into childhood rare diseases
-
Advancing novel gene therapies into the clinic
-
Study reveals potential new way to treat colorectal cancer
-
Startup wins first Advise & Connect Innovation Award
-
Milner Therapeutics Institute and LifeArc extend strategic partnership
-
New £4.25 million grant kick starts UK-wide collaborative research effort to end motor neuron disease
-
New £30 million translational partnership will accelerate development of new treatments for people with dementia
-
Promising new asthma medicine ready to enter early clinical trials
-
Pandemic Science Hub to develop better drugs to fight lung disease
-
Action Medical Research and LifeArc announce a fourth round of funding to support translational research into children’s rare diseases
-
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
-
Accelerating progress against dementia
